| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1e946da8881c61189e05c9200ea2e70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf3d3026e96f198427bc251f5fb5f297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccfa0ffe5f3f6875cf8477ba4d4b79c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a7e15d49a13fc949411fc86313a785e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2f99ca1d57b6b599009735df6994d10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2006-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e521a18bdd45b4e3da9c01f5f6d7c71c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed7f4d05985f940f383b21927d18001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba7500b0a529ec6147ef7bc718193ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3716e862c4f5ab7657649cacc859e1 |
| publicationDate |
2007-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007014749-A3 |
| titleOfInvention |
Regulation of tissue factor activity by protein s and tissue factor pathway inhibitor |
| abstract |
The present invention relates to methods for the identification of compounds that increase or decrease the inhibitory effect of TFPI on tissue factor activity and/or Factor Xa activity and/or thrombin formation. The invention also relates to methods for the identification of compounds that increase or decrease the co-factor activity of Protein S in TFPI-mediated inhibition of tissue factor and/or Factor Xa activity. The invention also relates to a pharmaceutical composition comprising the compounds identifiable by such methods. The invention also relates to methods for the regulation of tissue factor activity by influencing the interaction between Protein S and Tissue Factor Pathway Inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962563-B2 |
| priorityDate |
2005-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |